The activation of inflammatory pathways characteristic of NAFLD and NASH induces the production and release of some inflammatory, prothrombotic, and oxidative stress mediators, e.g., the cytokines IL6, TNFα, and IL1β. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.